Búsqueda | Biblioteca Virtual en Salud

Danta, Mark; Dore, Gregory J; Hennessy, Lisa; Li, Yueming; Vickers, Chris R; Harley, Hugh; Ngu, Meng; Reed, William; Desmond, Paul V; Sievert, William; Farrell, Geoff C; Kaldor, John M; Batey, Robert G.

Med J Aust ; 177(5): 240-5, 2002 Sep 02.

Artículo en Inglés | MEDLINE | ID: mdl-12197817

13.

Opioid overdose deaths can occur in patients with naltrexone implants.

Batey, Robert G.

Med J Aust ; 187(1): 55; author reply 56-7, 2007 Jul 02.

Artículo en Inglés | MEDLINE | ID: mdl-17605709

14.

Problem-based learning: a dissemination success story?

Batey, Robert G.

Med J Aust ; 184(2): 94-5, 2006 Jan 16.

Artículo en Inglés | MEDLINE | ID: mdl-16411883

15.

Australia's first religiously affiliated medical school.

Batey, Robert G.

Med J Aust ; 183(6): 332-3; author reply 333, 2005 Sep 19.

Artículo en Inglés | MEDLINE | ID: mdl-16276611

16.

Hepatitis C: where are we at and where are we going?

Batey, Robert G.

Med J Aust ; 176(8): 361-2, 2002 Apr 15.

Artículo en Inglés | MEDLINE | ID: mdl-12041627

17.

Cholestasis associated with the use of pravastatin sodium.

Batey, Robert G; Harvey, Michelle.

Med J Aust ; 176(11): 561, 2002 Jun 03.

Artículo en Inglés | MEDLINE | ID: mdl-12064992

18.

Injecting drug use in Australia: needle/syringe programs prove their worth, but hepatitis C still on the increase.

Law, Matthew G; Batey, Robert G.

Med J Aust ; 178(5): 197-8, 2003 Mar 03.

Artículo en Inglés | MEDLINE | ID: mdl-12603178

Biblioteca Virtual en Salud

Hipertensión

Su selección (0)

Formato de exportación:

Exportar:

Standards of liver cirrhosis care in Central Australia.

Involuntary treatment of drug and alcohol dependence in New South Wales: an old Act and a new direction.

Controversies in and challenges to our understanding of hepatitis C.

Role of ethanol in the regulation of hepatic stellate cell function.

Complementary and alternative medicine in the treatment of chronic liver disease.

The spectrum of thyroid dysfunction in an Australian hepatitis C population treated with combination Interferon-alpha2beta and Ribavirin.

The medical complications of alcohol use: understanding mechanisms to improve management.

Molecular pathogenesis of T lymphocyte-induced liver injury in alcoholic hepatitis.

Lymphocyte-mediated liver injury in alcohol-related hepatitis.

Chronic hepatitis C.

Pegylated interferon-alpha2beta in combination with ribavirin does not aggravate thyroid dysfunction in comparison to regular interferon-alpha2beta in a hepatitis C population: meta-analysis.

Factors associated with severity of hepatic fibrosis in people with chronic hepatitis C infection.

Opioid overdose deaths can occur in patients with naltrexone implants.

Problem-based learning: a dissemination success story?

Australia's first religiously affiliated medical school.

Hepatitis C: where are we at and where are we going?

Cholestasis associated with the use of pravastatin sodium.

Injecting drug use in Australia: needle/syringe programs prove their worth, but hepatitis C still on the increase.